Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting 2025-09-17 07:30
New Scientific Review Highlights β-Lactoglobulin's Dual Benefits for Metabolic and Muscle Health 2025-09-16 21:47
Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025 2025-09-16 21:00
ShiraTronics Announces Positive 12-Month Follow-Up Results from RELIEV-CM Pilot Study, Demonstrating Sustained Clinical Benefit with Investigational Implantable Neuromodulation Therapy for Chronic Migraine 2025-09-16 19:00
Celebrating Cross-Border Partnerships in Healthcare, Asia Medical Week 2025 Convened Leaders in Bali to Strengthen Excellence and Preparedness 2025-09-16 13:37
Akeso's Ligufalimab (CD47 mAb) Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia (AML) 2025-09-16 10:27
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025 2025-09-16 09:00
HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor 2025-09-15 21:30
Korea reinforces biopharma leadership at Global Bio Conference 2025 2025-09-15 20:30
Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2) 2025-09-15 20:00
Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity 2025-09-15 20:00
Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma 2025-09-15 12:11
Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc 2025-09-15 12:06
MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics 2025-09-15 11:53
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations 2025-09-15 08:00
Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101 2025-09-15 08:00
Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium 2025-09-15 07:45
/C O R R E C T I O N -- Mars/ 2025-09-13 06:14
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq 2025-09-12 20:00
Indication Expansion Accelerates: First Patient Dosed in Melanoma Phase 1b/II Trial of Opamtistomig 2025-09-12 12:39
1 18 19 20 21 22 525